Forums

Tradefair & Financials

There is currently 1 person viewing this thread.
jed.davison
29 Jan 14 16:33
Joined:
Date Joined: 16 Mar 11
| Topic/replies: 12,053 | Blogger: jed.davison's blog
Bought a few thousand of these in about 2004 after trying their Sativex (known to connoisseurs of the early version as "the Headmist"), were worth 39p in March last year, 253.75p about half an hour ago.

Post your reply

Text Format: Table: Smilies:
Forum does not support HTML
Insert Photo
Cancel
sort by:
Show
per page
Replies: 6
By:
jed.davison
When: 23 Jun 14 13:33
470 right now.
By:
lingbleed
When: 07 Jul 14 00:15
well done
By:
jed.davison
When: 26 Sep 16 15:24
£8.01 now LOL
By:
ditchbert
When: 30 Sep 16 12:51
£ 8.50 today. Do you still hold them.
By:
bongo
When: 01 Oct 16 13:19
Just been reading a little about GW.
Never made a profit
Don't pay a dividend for that reason
So it's a stock purely for gamblers, not for someone wanting a 3% dividend income because the best ISAs pay around 1%

Their headline product is prescription cannabinoid medications or something, so presumably aimed at people who want a palliative / pain killer. But it can't be long before a major territory in Europe follows Colorado and legalises cannabis. It could be Scotland - god knows their government needs the revenue. And jumping on the West Coast Main Line is fun, and consuming your pain killers together on easy chairs in a pungent licenced horticulturalists greenhouse is more sociable than visiting a GP earning 90k who treats you with a condescending attitude and for which you have to wait a week for an appointment. Legalising pot would then catch on across the continent, and has got to dent earnings prospects for GW.

On the other hand, I bet the people in the labs at GW know a lot about growing cannabis under glass, so their talents won't go to waste.
By:
jed.davison
When: 04 Oct 16 10:36
bongo, GW have just completed Stage Three trials for the application of Sativex for childhood epilepsy - two major causes Gestaut and Dravett's syndromes - typically these have been treatable, and not very efefctively, with other medicines with hideous side-effects.

Sativex at all stages of the trial has achieved amazing outcomes - drastic reductions in frequency of fits and no side effects whatsover. The market in the US alone just for this application is estimated to be worth £800m a year.

875 now.
sort by:
Show
per page

Post your reply

Text Format: Table: Smilies:
Forum does not support HTML
Insert Photo
Cancel
‹ back to topics
www.betfair.com